Baystate Wealth Management’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$190 Hold
200
﹤0.01% 1269
2023
Q3
$216 Hold
200
﹤0.01% 980
2023
Q2
$179 Hold
200
﹤0.01% 1014
2023
Q1
$169 Buy
+200
New +$219 ﹤0.01% 1005

Other funds holding CLOV

Baystate Wealth Management's CLOV Position: Q4 2023 in Review

Baystate Wealth Management held its Clover Health Investments (CLOV) position steady in Q4 2023 at 200 shares worth $190. The position accounts for ﹤0.01% of the portfolio, ranked #1269.

Baystate Wealth Management first reported a position in CLOV in Q1 2023 and has held it in 4 quarters since. The position peaked at $216 in Q3 2023. 144 funds tracked by Wall St. Rank hold CLOV as of Q4 2023.

  • Baystate Wealth Management held 200 shares of Clover Health Investments worth $190 as of Q4 2023.
  • Baystate Wealth Management left its Clover Health Investments share count unchanged in Q4 2023.
  • Clover Health Investments made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #1269 holding.
  • Baystate Wealth Management first reported a position in Clover Health Investments in Q1 2023 and has held it in 4 quarters since.
  • Baystate Wealth Management's Clover Health Investments position peaked at $216 in Q3 2023.
  • 144 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.